Lukas Kuhlmann

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Breast Cancer Cells

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Johanna Berfelde, Laura S Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold Valentin Distel
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. International journal of molecular sciences 25 (4) (2024)
Johanna Berfelde, Laura S Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold Valentin Distel
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. International journal of molecular sciences 25 (4) (2024)
Johanna Berfelde, Laura S Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold Valentin Distel
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. International journal of molecular sciences 25 (4) (2024)
Johanna Berfelde, Laura S Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold Valentin Distel
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. International journal of molecular sciences 25 (4) (2024)
Sarah Jesse, Lukas Kuhlmann, Laura S Hildebrand, Henriette Magelssen, Martina Schmaus, Beate Timmermann, Stephanie Andres, Sandra Rutzner, Luitpold Valentin Distel
Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome. Cells 12 (5) (2023)
Sarah Jesse, Lukas Kuhlmann, Laura S Hildebrand, Henriette Magelssen, Martina Schmaus, Beate Timmermann, Stephanie Andres, Sandra Rutzner, Luitpold Valentin Distel
Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome. Cells 12 (5) (2023)
Sarah Jesse, Lukas Kuhlmann, Laura S Hildebrand, Henriette Magelssen, Martina Schmaus, Beate Timmermann, Stephanie Andres, Sandra Rutzner, Luitpold Valentin Distel
Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome. Cells 12 (5) (2023)